TCR usage in CTLs recognizing melanoma/melanocyte antigens
- 31 December 1995
- journal article
- other
- Published by Elsevier BV in Immunology Today
- Vol. 16 (12), 603-604
- https://doi.org/10.1016/0167-5699(95)80084-0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- T-cell repertoire diversity and clonal expansions in normal and clinical samplesImmunology Today, 1995
- Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.The Journal of Experimental Medicine, 1995
- Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.Proceedings of the National Academy of Sciences of the United States of America, 1994
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.The Journal of Experimental Medicine, 1994
- T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.The Journal of Experimental Medicine, 1993
- Antigen-selected T-cell receptor diversity and self-nonself homologyImmunology Today, 1993
- The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1993